| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | potassium:chloride symporter activity | 9.44e-07 | 9 | 189 | 4 | GO:0015379 | |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | SLC5A6 SLC12A6 SLC17A4 SLC6A2 SLC17A5 SLC12A3 SLC12A4 SLC2A13 SLC12A7 | 1.99e-06 | 119 | 189 | 9 | GO:0015294 |
| GeneOntologyMolecularFunction | chloride:monoatomic cation symporter activity | 2.11e-06 | 23 | 189 | 5 | GO:0015377 | |
| GeneOntologyMolecularFunction | monoatomic anion:monoatomic cation symporter activity | 4.03e-06 | 26 | 189 | 5 | GO:0015296 | |
| GeneOntologyMolecularFunction | symporter activity | SLC5A6 SLC12A6 SLC17A4 SLC6A2 SLC17A5 SLC12A3 SLC12A4 SLC2A13 SLC12A7 | 1.33e-05 | 150 | 189 | 9 | GO:0015293 |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | CLCA1 SLC5A6 VDAC2 SLC12A6 SLC6A2 SLC12A3 SLC12A4 LRRC8B SLC12A7 | 1.40e-05 | 151 | 189 | 9 | GO:0008509 |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | CLCA1 SLC5A6 SLC12A6 SLC17A4 ABCC6 SLC6A2 SLC12A3 SLC12A4 SLC12A7 | 3.76e-05 | 171 | 189 | 9 | GO:0015103 |
| GeneOntologyMolecularFunction | enzyme regulator activity | PABIR1 A2M ERCC5 MYCBP2 ARHGEF38 CD55 BIRC6 SERPINI2 FGD5 HERC2 PZP GCN1 AGAP4 PREX1 ARHGAP21 AGAP1 RICTOR RGS12 PREX2 VAC14 IGF1 SIPA1L1 MAP3K13 LTF AGAP9 AGAP7P AGAP6 ELP4 | 1.69e-04 | 1418 | 189 | 28 | GO:0030234 |
| GeneOntologyMolecularFunction | ammonium channel activity | 1.72e-04 | 12 | 189 | 3 | GO:0008519 | |
| GeneOntologyMolecularFunction | enzyme activator activity | ERCC5 GCN1 AGAP4 PREX1 ARHGAP21 AGAP1 RICTOR RGS12 PREX2 VAC14 IGF1 SIPA1L1 MAP3K13 LTF AGAP9 AGAP7P AGAP6 | 1.74e-04 | 656 | 189 | 17 | GO:0008047 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | CLCA1 KCNH1 SLC5A6 PKD1 VDAC2 SLC12A6 CACNA1C SLC17A4 GRID2 GRIK1 SLC6A2 KCNV1 SLC17A5 SLC12A3 SLC12A4 P2RX2 LRRC8B SLC2A13 SLC12A7 | 1.97e-04 | 793 | 189 | 19 | GO:0015075 |
| GeneOntologyMolecularFunction | GTPase activator activity | AGAP4 PREX1 ARHGAP21 AGAP1 RGS12 PREX2 SIPA1L1 AGAP9 AGAP7P AGAP6 | 3.39e-04 | 279 | 189 | 10 | GO:0005096 |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | MYCBP2 ARHGEF38 FGD5 HERC2 AGAP4 PREX1 ARHGAP21 AGAP1 RGS12 PREX2 SIPA1L1 AGAP9 AGAP7P AGAP6 | 3.50e-04 | 507 | 189 | 14 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | MYCBP2 ARHGEF38 FGD5 HERC2 AGAP4 PREX1 ARHGAP21 AGAP1 RGS12 PREX2 SIPA1L1 AGAP9 AGAP7P AGAP6 | 3.50e-04 | 507 | 189 | 14 | GO:0030695 |
| GeneOntologyMolecularFunction | channel activity | CLCA1 KCNH1 PKD1 GJA10 VDAC2 SLC12A6 CACNA1C GRID2 GRIK1 KCNV1 SLC12A4 P2RX2 LRRC8B SLC12A7 | 4.95e-04 | 525 | 189 | 14 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | CLCA1 KCNH1 PKD1 GJA10 VDAC2 SLC12A6 CACNA1C GRID2 GRIK1 KCNV1 SLC12A4 P2RX2 LRRC8B SLC12A7 | 5.04e-04 | 526 | 189 | 14 | GO:0022803 |
| GeneOntologyMolecularFunction | transporter activity | C2CD2L CLCA1 KCNH1 SLC5A6 PKD1 GJA10 VDAC2 SLC12A6 CACNA1C SLC17A4 GRID2 GRIK1 ATP10A ABCC6 SLC6A2 KCNV1 SLC17A5 SLC12A3 SLC12A4 P2RX2 LRP2 DISP2 LRRC8B SLC2A13 SLC12A7 | 5.06e-04 | 1289 | 189 | 25 | GO:0005215 |
| GeneOntologyMolecularFunction | phospholipid binding | AMER1 C2CD2L KCNH1 AGAP4 PREX1 VDAC2 AGAP1 TECPR1 SGIP1 ZFYVE28 P2RX2 AGAP9 AGAP7P AGAP6 | 7.52e-04 | 548 | 189 | 14 | GO:0005543 |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activator activity | 8.70e-04 | 78 | 189 | 5 | GO:0043539 | |
| GeneOntologyMolecularFunction | potassium ion transmembrane transporter activity | 1.08e-03 | 167 | 189 | 7 | GO:0015079 | |
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | 1.23e-03 | 125 | 189 | 6 | GO:0015108 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | KCNH1 SLC5A6 PKD1 SLC12A6 CACNA1C SLC17A4 GRIK1 SLC6A2 KCNV1 SLC12A3 SLC12A4 SLC12A7 | 1.64e-03 | 465 | 189 | 12 | GO:0046873 |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | KCNH1 SLC5A6 PKD1 SLC12A6 CACNA1C SLC17A4 GRIK1 SLC6A2 KCNV1 SLC17A5 SLC12A3 SLC12A4 P2RX2 SLC2A13 SLC12A7 | 1.68e-03 | 664 | 189 | 15 | GO:0008324 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | CLCA1 KCNH1 SLC5A6 PKD1 GJA10 VDAC2 SLC12A6 CACNA1C SLC17A4 GRID2 GRIK1 ABCC6 SLC6A2 KCNV1 SLC17A5 SLC12A3 SLC12A4 P2RX2 DISP2 LRRC8B SLC2A13 SLC12A7 | 1.84e-03 | 1180 | 189 | 22 | GO:0022857 |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | SLC5A6 SLC12A6 SLC17A4 SLC6A2 SLC17A5 SLC12A3 SLC12A4 SLC2A13 SLC12A7 | 2.10e-03 | 296 | 189 | 9 | GO:0015291 |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | SLC5A6 SLC12A6 SLC17A4 SLC6A2 SLC17A5 SLC12A3 SLC12A4 SLC2A13 SLC12A7 | 2.35e-03 | 301 | 189 | 9 | GO:0022853 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | CLCA1 KCNH1 SLC5A6 PKD1 SLC12A6 CACNA1C SLC17A4 GRIK1 ABCC6 SLC6A2 KCNV1 SLC17A5 SLC12A3 SLC12A4 SLC2A13 SLC12A7 | 2.35e-03 | 758 | 189 | 16 | GO:0015318 |
| GeneOntologyMolecularFunction | diacylglycerol O-acyltransferase activity | 2.40e-03 | 8 | 189 | 2 | GO:0004144 | |
| GeneOntologyMolecularFunction | 2-acylglycerol O-acyltransferase activity | 2.40e-03 | 8 | 189 | 2 | GO:0003846 | |
| GeneOntologyBiologicalProcess | monoatomic anion transport | CLCA1 SLC5A6 VDAC2 SLC12A6 SLC17A4 ABCC6 SLC17A5 SLC12A3 SLC12A4 LRRC8B SLC12A7 | 1.21e-06 | 183 | 192 | 11 | GO:0006820 |
| GeneOntologyBiologicalProcess | ammonium import across plasma membrane | 3.15e-06 | 4 | 192 | 3 | GO:0140157 | |
| GeneOntologyBiologicalProcess | monoatomic anion transmembrane transport | CLCA1 SLC5A6 VDAC2 SLC12A6 ABCC6 SLC12A3 SLC12A4 LRRC8B SLC12A7 | 1.37e-05 | 153 | 192 | 9 | GO:0098656 |
| GeneOntologyBiologicalProcess | organelle fission | SPIRE2 STRA8 MEIOB CUL7 USP44 NEUROG1 BRCA2 ANLN NFIX RAD51B CEP85 OBSL1 COX10 CEP192 FANCM IGF1 TMCC1 | 2.62e-05 | 571 | 192 | 17 | GO:0048285 |
| GeneOntologyBiologicalProcess | regulation of cell cycle process | PABIR1 STRA8 BARD1 CUL7 BIRC6 USP44 NEUROG1 BRCA2 ANLN PKD1 MBD4 DYNC1H1 CUL4B RAD51B CEP85 OBSL1 CEP192 KIF20A IGF1 SUSD2 SENP2 | 4.25e-05 | 845 | 192 | 21 | GO:0010564 |
| GeneOntologyBiologicalProcess | regulation of GTPase activity | MKKS FGD5 MAP4K4 AGAP4 PREX1 AGAP1 RICTOR PREX2 SIPA1L1 AGAP9 AGAP7P AGAP6 | 7.51e-05 | 335 | 192 | 12 | GO:0043087 |
| GeneOntologyBiologicalProcess | chloride ion homeostasis | 7.90e-05 | 25 | 192 | 4 | GO:0055064 | |
| GeneOntologyBiologicalProcess | Wnt receptor catabolic process | 8.62e-05 | 2 | 192 | 2 | GO:0038018 | |
| GeneOntologyBiologicalProcess | nuclear division | SPIRE2 STRA8 MEIOB CUL7 USP44 NEUROG1 BRCA2 ANLN NFIX RAD51B CEP85 OBSL1 CEP192 FANCM IGF1 | 9.47e-05 | 512 | 192 | 15 | GO:0000280 |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | NEDD4 CLCA1 KCNH1 SLC5A6 PKD1 VDAC2 SLC12A6 CACNA1C SLC17A4 GRID2 GRIK1 ATP10A ABCC6 CEMIP SLC6A2 KCNV1 SLC17A5 SLC12A3 SLC12A4 P2RX2 ISCU LRRC8B SLC12A7 NNT | 1.14e-04 | 1115 | 192 | 24 | GO:0034220 |
| GeneOntologyBiologicalProcess | monoatomic anion homeostasis | 1.25e-04 | 28 | 192 | 4 | GO:0055081 | |
| GeneOntologyBiologicalProcess | regulation of mitotic cell cycle | PABIR1 BARD1 CUL7 USP44 NEUROG1 BRCA2 ANLN PKD1 MBD4 CUL4B RAD51B OBSL1 CEP192 GMNN IGF1 SENP2 | 1.46e-04 | 594 | 192 | 16 | GO:0007346 |
| GeneOntologyBiologicalProcess | monoatomic ion transport | NEDD4 CLCA1 KCNH1 SLC5A6 PKD1 VDAC2 SLC12A6 CACNA1C SLC17A4 GRID2 GRIK1 ATP10A ABCC6 CEMIP SLC6A2 KCNV1 SLC17A5 IGF1 SLC12A3 SLC12A4 P2RX2 ISCU LRP2 LRRC8B LTF SLC12A7 NNT | 1.86e-04 | 1374 | 192 | 27 | GO:0006811 |
| GeneOntologyBiologicalProcess | ammonium transmembrane transport | 2.12e-04 | 13 | 192 | 3 | GO:0072488 | |
| GeneOntologyBiologicalProcess | protein ubiquitination | AMER1 MYCBP2 RNF19B BARD1 CUL7 BIRC6 RNF43 NEDD4 USP44 ZNRF3 USP4 HERC2 CUL4B PHRF1 FANCM TRIM7 KLHL15 SENP2 WDSUB1 | 2.14e-04 | 811 | 192 | 19 | GO:0016567 |
| MousePheno | absent pinna reflex | 4.25e-06 | 89 | 147 | 8 | MP:0006358 | |
| MousePheno | fused cornea and lens | 4.35e-06 | 24 | 147 | 5 | MP:0001307 | |
| MousePheno | abnormal pinna reflex | 1.09e-05 | 101 | 147 | 8 | MP:0001485 | |
| MousePheno | abnormal lens development | 1.74e-05 | 78 | 147 | 7 | MP:0005545 | |
| MousePheno | cornea opacity | 4.59e-05 | 159 | 147 | 9 | MP:0001314 | |
| Domain | SLC12A_fam | 3.26e-07 | 7 | 186 | 4 | IPR004842 | |
| Domain | SLC12_C | 6.46e-07 | 8 | 186 | 4 | IPR018491 | |
| Domain | SLC12 | 6.46e-07 | 8 | 186 | 4 | PF03522 | |
| Domain | KCL_cotranspt | 3.86e-06 | 4 | 186 | 3 | IPR000076 | |
| Domain | ArfGap | 9.08e-06 | 29 | 186 | 5 | SM00105 | |
| Domain | ARFGAP | 9.08e-06 | 29 | 186 | 5 | PS50115 | |
| Domain | ArfGap | 9.08e-06 | 29 | 186 | 5 | PF01412 | |
| Domain | ArfGAP | 9.08e-06 | 29 | 186 | 5 | IPR001164 | |
| Domain | APC_su10/DOC_dom | 3.30e-05 | 7 | 186 | 3 | IPR004939 | |
| Domain | DOC | 3.30e-05 | 7 | 186 | 3 | PS51284 | |
| Domain | ANAPC10 | 3.30e-05 | 7 | 186 | 3 | PF03256 | |
| Domain | APC10 | 3.30e-05 | 7 | 186 | 3 | SM01337 | |
| Domain | AA-permease/SLC12A_dom | 6.05e-05 | 22 | 186 | 4 | IPR004841 | |
| Domain | AA_permease | 6.05e-05 | 22 | 186 | 4 | PF00324 | |
| Domain | KCC1 | 9.86e-05 | 2 | 186 | 2 | IPR000622 | |
| Domain | PH | ANLN FGD5 AGAP4 PREX1 ARHGAP21 AGAP1 TECPR1 PREX2 AGAP9 AGAP7P AGAP6 | 1.12e-04 | 278 | 186 | 11 | SM00233 |
| Domain | PH_DOMAIN | ANLN FGD5 AGAP4 PREX1 ARHGAP21 AGAP1 TECPR1 PREX2 AGAP9 AGAP7P AGAP6 | 1.15e-04 | 279 | 186 | 11 | PS50003 |
| Domain | PH_domain | ANLN FGD5 AGAP4 PREX1 ARHGAP21 AGAP1 TECPR1 PREX2 AGAP9 AGAP7P AGAP6 | 1.19e-04 | 280 | 186 | 11 | IPR001849 |
| Domain | - | BRPF3 SPIRE2 MYCBP2 RNF19B BARD1 RNF43 USP44 TRIM66 ZNRF3 FGD5 PHRF1 TRIM7 ZFYVE28 WDSUB1 | 1.69e-04 | 449 | 186 | 14 | 3.30.40.10 |
| Domain | Znf_RING/FYVE/PHD | BRPF3 SPIRE2 MYCBP2 RNF19B BARD1 RNF43 USP44 TRIM66 ZNRF3 FGD5 PHRF1 TRIM7 ZFYVE28 WDSUB1 | 2.12e-04 | 459 | 186 | 14 | IPR013083 |
| Domain | Cul7 | 2.94e-04 | 3 | 186 | 2 | PF11515 | |
| Domain | TECPR | 2.94e-04 | 3 | 186 | 2 | SM00706 | |
| Domain | CPH_domain | 2.94e-04 | 3 | 186 | 2 | IPR021097 | |
| Domain | Beta-propeller_rpt_TECPR | 2.94e-04 | 3 | 186 | 2 | IPR006624 | |
| Domain | PH_dom-like | ANLN FGD5 AGAP4 PREX1 ARHGAP21 AGAP1 TECPR1 RGS12 PREX2 LRBA AGAP9 AGAP7P AGAP6 | 3.55e-04 | 426 | 186 | 13 | IPR011993 |
| Domain | - | IFT140 BIRC6 BRWD3 SEMA6D SEMA3B SEC13 KIF21A WDR87 SMU1 LRBA WDSUB1 | 5.26e-04 | 333 | 186 | 11 | 2.130.10.10 |
| Domain | WD40/YVTN_repeat-like_dom | IFT140 BIRC6 BRWD3 SEMA6D SEMA3B SEC13 KIF21A WDR87 SMU1 LRBA WDSUB1 | 5.53e-04 | 335 | 186 | 11 | IPR015943 |
| Pathway | REACTOME_CATION_COUPLED_CHLORIDE_COTRANSPORTERS | 3.47e-07 | 7 | 143 | 4 | M27339 | |
| Pathway | REACTOME_CATION_COUPLED_CHLORIDE_COTRANSPORTERS | 3.47e-07 | 7 | 143 | 4 | MM15081 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SYNRG SPIRE2 PCNX3 MYCBP2 PRAG1 BIRC6 RNF43 C2CD2L ZGPAT ZNRF3 RRP12 BANP PKD1 HERC2 GCN1 PREX1 ARHGAP21 CRAMP1 DYNC1H1 LRFN1 KHNYN CEP192 POM121C C2CD2 TRIM7 VAC14 SLC12A4 LMX1B TTLL4 NINL DISP2 SENP2 LRBA PRRT4 | 6.18e-16 | 1105 | 195 | 34 | 35748872 |
| Pubmed | TRO GPATCH8 RUSC2 NEDD4 C2CD2L SEMA6D RRP12 BOD1L1 ARHGAP21 DYNC1H1 KHNYN OBSL1 CEP192 SIPA1L1 MACF1 PPIP5K1 DISP2 SENP2 CIPC | 2.14e-12 | 407 | 195 | 19 | 12693553 | |
| Pubmed | GGAPs, a new family of bifunctional GTP-binding and GTPase-activating proteins. | 6.51e-10 | 9 | 195 | 5 | 12640130 | |
| Pubmed | AGAP1/AP-3-dependent endocytic recycling of M5 muscarinic receptors promotes dopamine release. | 1.30e-09 | 10 | 195 | 5 | 20664521 | |
| Pubmed | AGAP1, a novel binding partner of nitric oxide-sensitive guanylyl cyclase. | 2.37e-09 | 11 | 195 | 5 | 15381706 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | PABIR1 TET2 SYNRG SPIRE2 AMER1 MYCBP2 PRAG1 RUSC2 NEDD4 ANLN NHS BOD1L1 MAP4K4 ARHGAP21 PAK5 RICTOR CEP192 RGS12 SIPA1L1 ISCU MACF1 TMCC1 | 3.89e-09 | 861 | 195 | 22 | 36931259 |
| Pubmed | SMG1 MYCBP2 BIRC6 C2CD2L ZNRF3 GCN1 PREX1 CUL4B OBSL1 SIPA1L1 MACF1 SENP2 | 6.33e-09 | 225 | 195 | 12 | 12168954 | |
| Pubmed | 6.53e-09 | 13 | 195 | 5 | 27713690 | ||
| Pubmed | TET2 SMG1 IFT140 BRPF3 MAP4K4 AGAP4 CRAMP1 AGAP1 KIF21A PHRF1 FNBP4 ZFYVE28 TTLL4 NINL AGAP9 AGAP7P AGAP6 | 9.38e-09 | 529 | 195 | 17 | 14621295 | |
| Pubmed | 1.01e-08 | 14 | 195 | 5 | 22453919 | ||
| Pubmed | The TRIM9/TRIM67 neuronal interactome reveals novel activators of morphogenesis. | PRAG1 MAP4K4 AGAP4 VDAC2 AGAP1 CEP85 SIPA1L1 SMU1 AGAP9 AGAP7P AGAP6 | 4.85e-08 | 218 | 195 | 11 | 33378226 |
| Pubmed | Similar effects of all WNK3 variants on SLC12 cotransporters. | 6.59e-08 | 8 | 195 | 4 | 21613606 | |
| Pubmed | 1.18e-07 | 9 | 195 | 4 | 19323993 | ||
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | SMG1 BIRC6 NEDD4 ADRA1B HERC2 MAP4K4 ARHGAP21 RICTOR CEP192 TRAPPC8 C2CD2 RGS12 SLC12A4 CDK5RAP1 TMF1 MACF1 LRBA SLC12A7 | 1.48e-07 | 719 | 195 | 18 | 35337019 |
| Pubmed | 1.74e-07 | 3 | 195 | 3 | 11551954 | ||
| Pubmed | 1.74e-07 | 3 | 195 | 3 | 15262997 | ||
| Pubmed | K-Cl cotransporter gene expression during human and murine erythroid differentiation. | 1.74e-07 | 3 | 195 | 3 | 21733850 | |
| Pubmed | 1.74e-07 | 3 | 195 | 3 | 17133354 | ||
| Pubmed | ADAMTS9 BOD1L1 HEATR5B ZNF471 PREX1 ARHGAP21 CRAMP1 TECPR1 SENP2 | 2.26e-07 | 153 | 195 | 9 | 10718198 | |
| Pubmed | 6.91e-07 | 4 | 195 | 3 | 12637262 | ||
| Pubmed | 7.66e-07 | 130 | 195 | 8 | 12421765 | ||
| Pubmed | TET2 MYCBP2 BRWD3 TRIM66 ADAMTS9 PKD1 HERC2 MBD4 MAP4K4 PREX1 ARHGAP21 DYNC1H1 AGAP1 CNTN4 CEP85 KIF21A OBSL1 GRIK1 SIPA1L1 LRP2 MACF1 CIPC LRBA | 1.02e-06 | 1285 | 195 | 23 | 35914814 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | AMER1 MYCBP2 ARHGEF38 BARD1 ALX4 BRWD3 NFIX BANP SEMA3B BOD1L1 CRAMP1 AGAP1 RAD51B SLC12A6 CACNA1C FNBP4 GRIK1 CEP192 ATP10A C2CD2 IGF1 CDK5RAP1 MACF1 LRBA TMCC1 | 1.06e-06 | 1489 | 195 | 25 | 28611215 |
| Pubmed | RNF43 NHS MAP4K4 GCN1 ARHGAP21 KHNYN POM121C MACF1 SENP2 LRBA | 2.62e-06 | 263 | 195 | 10 | 34702444 | |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | PRAG1 NEDD4 AGAP4 DYNC1H1 AGAP1 SIPA1L1 MACF1 AGAP9 AGAP7P AGAP6 | 4.71e-06 | 281 | 195 | 10 | 28706196 |
| Pubmed | CUL7 BIRC6 TRIM66 ADAMTS9 PREX1 CNTN4 RICTOR TRAPPC8 FANCM POM121C ATP10A MACF1 TMCC1 | 4.84e-06 | 493 | 195 | 13 | 15368895 | |
| Pubmed | P-Rex1 links mammalian target of rapamycin signaling to Rac activation and cell migration. | 5.98e-06 | 7 | 195 | 3 | 17565979 | |
| Pubmed | 5.98e-06 | 7 | 195 | 3 | 36700049 | ||
| Pubmed | Rare independent mutations in renal salt handling genes contribute to blood pressure variation. | 6.48e-06 | 22 | 195 | 4 | 18391953 | |
| Pubmed | 9.52e-06 | 8 | 195 | 3 | 11395011 | ||
| Pubmed | The WNK-regulated SPAK/OSR1 kinases directly phosphorylate and inhibit the K+-Cl- co-transporters. | 9.52e-06 | 8 | 195 | 3 | 24393035 | |
| Pubmed | 9.52e-06 | 8 | 195 | 3 | 12386165 | ||
| Pubmed | An approach based on a genome-wide association study reveals candidate loci for narcolepsy. | 1.44e-05 | 193 | 195 | 8 | 20677014 | |
| Pubmed | SYNRG MYCBP2 ANLN BOD1L1 MAP4K4 GCN1 DYNC1H1 VDAC2 CEP85 FNBP4 SMU1 LRBA ELP4 | 1.52e-05 | 549 | 195 | 13 | 38280479 | |
| Pubmed | MYCBP2 CUL7 BIRC6 RRP12 HERC2 GCN1 DYNC1H1 SEC13 CUL4B PHRF1 SMU1 MACF1 LTF NNT | 2.14e-05 | 653 | 195 | 14 | 22586326 | |
| Pubmed | Targeted proteomic analysis of 14-3-3 sigma, a p53 effector commonly silenced in cancer. | 2.48e-05 | 102 | 195 | 6 | 15778465 | |
| Pubmed | 2.62e-05 | 103 | 195 | 6 | 10574462 | ||
| Pubmed | 2.77e-05 | 104 | 195 | 6 | 9205841 | ||
| Pubmed | RNF43 and ZNRF3 are commonly altered in serrated pathway colorectal tumorigenesis. | 3.13e-05 | 2 | 195 | 2 | 27661107 | |
| Pubmed | 3.13e-05 | 2 | 195 | 2 | 24447081 | ||
| Pubmed | 3.13e-05 | 2 | 195 | 2 | 34597859 | ||
| Pubmed | Identification and characterization of TMEM24 family genes in silico. | 3.13e-05 | 2 | 195 | 2 | 15289880 | |
| Pubmed | 3.13e-05 | 2 | 195 | 2 | 33788257 | ||
| Pubmed | 3.13e-05 | 2 | 195 | 2 | 29330115 | ||
| Pubmed | ZNRF3 and RNF43 cooperate to safeguard metabolic liver zonation and hepatocyte proliferation. | 3.13e-05 | 2 | 195 | 2 | 34129813 | |
| Pubmed | 3.13e-05 | 2 | 195 | 2 | 30980518 | ||
| Pubmed | Evaluation of Expression of LRBA and CTLA-4 Proteins in Common Variable Immunodeficiency Patients. | 3.13e-05 | 2 | 195 | 2 | 33191838 | |
| Pubmed | Genetic disruption of KCC cotransporters in a mouse model of thalassemia intermedia. | 3.13e-05 | 2 | 195 | 2 | 31835175 | |
| Pubmed | 3.13e-05 | 2 | 195 | 2 | 20543991 | ||
| Pubmed | P-Rex2 regulates Purkinje cell dendrite morphology and motor coordination. | 3.13e-05 | 2 | 195 | 2 | 18334636 | |
| Pubmed | E3 ligases RNF43 and ZNRF3 display differential specificity for endocytosis of Frizzled receptors. | 3.13e-05 | 2 | 195 | 2 | 38969364 | |
| Pubmed | 14-3-3 proteins regulate cullin 7-mediated Eag1 degradation. | 3.13e-05 | 2 | 195 | 2 | 36717938 | |
| Pubmed | 3.13e-05 | 2 | 195 | 2 | 17396115 | ||
| Pubmed | 3.13e-05 | 2 | 195 | 2 | 33008143 | ||
| Pubmed | 3.13e-05 | 2 | 195 | 2 | 28710285 | ||
| Pubmed | Polycystin-1 Is a Cardiomyocyte Mechanosensor That Governs L-Type Ca2+ Channel Protein Stability. | 3.13e-05 | 2 | 195 | 2 | 25888683 | |
| Pubmed | A complex of the lipid transport ER proteins TMEM24 and C2CD2 with band 4.1 at cell-cell contacts. | 3.13e-05 | 2 | 195 | 2 | 39158698 | |
| Pubmed | 3.13e-05 | 2 | 195 | 2 | 28856441 | ||
| Pubmed | 3.13e-05 | 2 | 195 | 2 | 10347194 | ||
| Pubmed | Cullins in human intra-uterine growth restriction: expressional and epigenetic alterations. | 3.13e-05 | 2 | 195 | 2 | 20005570 | |
| Pubmed | 3.13e-05 | 2 | 195 | 2 | 21220429 | ||
| Pubmed | Phospho-regulation, nucleotide binding and ion access control in potassium-chloride cotransporters. | 3.13e-05 | 2 | 195 | 2 | 34031912 | |
| Pubmed | 3.13e-05 | 2 | 195 | 2 | 26206937 | ||
| Pubmed | 3.13e-05 | 2 | 195 | 2 | 23052569 | ||
| Pubmed | 3.13e-05 | 2 | 195 | 2 | 1692292 | ||
| Pubmed | 3.13e-05 | 2 | 195 | 2 | 20694145 | ||
| Pubmed | SLC12A ion transporter mutations in sporadic and familial human congenital hydrocephalus. | 3.13e-05 | 2 | 195 | 2 | 31393094 | |
| Pubmed | The BARD1 Cys557Ser variant and breast cancer risk in Iceland. | 3.13e-05 | 2 | 195 | 2 | 16768547 | |
| Pubmed | Molecular cloning of two partial serotonin 5-HT1D receptor sequences in mouse and one in guinea pig. | 3.13e-05 | 2 | 195 | 2 | 1521164 | |
| Pubmed | 3.13e-05 | 2 | 195 | 2 | 18791038 | ||
| Pubmed | Mitochondrial respiration controls neoangiogenesis during wound healing and tumour growth. | 3.13e-05 | 2 | 195 | 2 | 32694534 | |
| Pubmed | 3.13e-05 | 2 | 195 | 2 | 35491430 | ||
| Pubmed | 3.13e-05 | 2 | 195 | 2 | 38169650 | ||
| Pubmed | 3.13e-05 | 2 | 195 | 2 | 11811950 | ||
| Pubmed | Rictor/mTORC2 deficiency enhances keratinocyte stress tolerance via mitohormesis. | 3.13e-05 | 2 | 195 | 2 | 28211872 | |
| Pubmed | 3.13e-05 | 2 | 195 | 2 | 28159733 | ||
| Pubmed | Pulmonary manifestations of immune dysregulation in CTLA-4 haploinsufficiency and LRBA deficiency. | 3.13e-05 | 2 | 195 | 2 | 33710794 | |
| Pubmed | 3.13e-05 | 2 | 195 | 2 | 17510708 | ||
| Pubmed | 3.13e-05 | 2 | 195 | 2 | 35039505 | ||
| Pubmed | Toll-like receptor 5 and 7 expression in adenoid cystic carcinoma of major salivary glands. | 3.13e-05 | 2 | 195 | 2 | 26888781 | |
| Pubmed | 3.13e-05 | 2 | 195 | 2 | 30530390 | ||
| Pubmed | 3.13e-05 | 2 | 195 | 2 | 19473567 | ||
| Pubmed | 3.13e-05 | 2 | 195 | 2 | 28601686 | ||
| Pubmed | HERC2 AGAP4 ARHGAP21 AGAP1 SGIP1 SIPA1L1 MACF1 MAP3K13 AGAP9 AGAP7P AGAP6 | 3.47e-05 | 430 | 195 | 11 | 32581705 | |
| Pubmed | PCNX3 CD55 GPATCH8 C2CD2L ZGPAT ANLN SLC5A6 RRP12 HERC2 HEATR5B MBD4 PREX1 VDAC2 AGAP1 SEC13 PHRF1 RICTOR SIPA1L1 SMU1 TMF1 MACF1 TMCC1 | 3.83e-05 | 1497 | 195 | 22 | 31527615 | |
| Pubmed | AMER1 ERCC5 CD55 GPATCH8 ANLN KCNH1 BOD1L1 ARHGAP21 KRT84 RICTOR CEP192 GLB1L2 SLC6A2 SIPA1L1 TTLL4 LRP2 MACF1 CIPC | 4.35e-05 | 1084 | 195 | 18 | 11544199 | |
| Pubmed | Reconstructing human brown fat developmental trajectory in vitro. | 4.76e-05 | 13 | 195 | 3 | 37647896 | |
| Pubmed | A genome-wide association study on common SNPs and rare CNVs in anorexia nervosa. | 4.76e-05 | 13 | 195 | 3 | 21079607 | |
| Pubmed | Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette. | TET2 NEDD4 MAP4K4 AGAP4 AGAP1 CEP85 FNBP4 SIPA1L1 TTLL4 AGAP9 AGAP7P AGAP6 | 5.56e-05 | 536 | 195 | 12 | 15840001 |
| Pubmed | TET2 NEDD4 MAP4K4 AGAP4 AGAP1 CEP85 FNBP4 SIPA1L1 TTLL4 AGAP9 AGAP7P AGAP6 | 5.76e-05 | 538 | 195 | 12 | 10512203 | |
| Pubmed | IFT140 BRPF3 CUL7 RNF43 BRWD3 C2CD2L TRIM66 ZNRF3 CUL4B PHRF1 OBSL1 RICTOR POM121C KIF20A SIPA1L1 LRP2 MACF1 LRRC8B | 6.30e-05 | 1116 | 195 | 18 | 31753913 | |
| Pubmed | BARD1 GPATCH8 CUL7 BRCA2 MBD4 ARHGAP21 CUL4B RAD51B IGHA1 SMU1 MACF1 LTF NNT | 6.65e-05 | 634 | 195 | 13 | 34591612 | |
| Pubmed | ZNRF3 functions in mammalian sex determination by inhibiting canonical WNT signaling. | 7.51e-05 | 15 | 195 | 3 | 29735715 | |
| Pubmed | 9.21e-05 | 16 | 195 | 3 | 35127681 | ||
| Pubmed | Nedd4-2 modulates renal Na+-Cl- cotransporter via the aldosterone-SGK1-Nedd4-2 pathway. | 9.35e-05 | 3 | 195 | 2 | 21852580 | |
| Pubmed | 9.35e-05 | 3 | 195 | 2 | 18045956 | ||
| Pubmed | 9.35e-05 | 3 | 195 | 2 | 19887603 | ||
| Pubmed | 9.35e-05 | 3 | 195 | 2 | 18812566 | ||
| Pubmed | 9.35e-05 | 3 | 195 | 2 | 26010302 | ||
| Pubmed | 9.35e-05 | 3 | 195 | 2 | 31034883 | ||
| Interaction | TOP3B interactions | SYNRG SPIRE2 PCNX3 MYCBP2 PRAG1 BIRC6 RNF43 C2CD2L ZGPAT ZNRF3 RRP12 BANP PKD1 HERC2 GCN1 PREX1 ARHGAP21 CRAMP1 DYNC1H1 VDAC2 LRFN1 KHNYN CEP192 POM121C C2CD2 TRIM7 VAC14 SLC12A4 LMX1B TTLL4 NINL DISP2 SENP2 LRBA PRRT4 | 3.18e-07 | 1470 | 190 | 35 | int:TOP3B |
| Interaction | KRT8 interactions | SMG1 KRT26 BIRC6 ANLN PKD1 USP4 FGD5 ARHGAP21 KRT14 CEP85 KRT84 OBSL1 RICTOR CEP192 ADAM12 SIPA1L1 NINL | 1.02e-06 | 441 | 190 | 17 | int:KRT8 |
| Interaction | YWHAG interactions | PABIR1 TET2 SYNRG SPIRE2 AMER1 MYCBP2 CUL7 PRAG1 RUSC2 NEDD4 C2CD2L ANLN NHS BOD1L1 MAP4K4 ARHGAP21 DYNC1H1 AGAP1 PAK5 RICTOR CEP192 RGS12 SIPA1L1 ISCU NINL MACF1 PPIP5K1 LRBA TMCC1 | 6.09e-06 | 1248 | 190 | 29 | int:YWHAG |
| Interaction | SFN interactions | PABIR1 TET2 SYNRG SPIRE2 MYCBP2 RUSC2 ANLN BANP NHS USP4 MAP4K4 ARHGAP21 RICTOR CEP192 RGS12 SIPA1L1 ISCU NINL MACF1 TMCC1 | 9.15e-06 | 692 | 190 | 20 | int:SFN |
| Interaction | YWHAH interactions | PABIR1 TET2 SYNRG SPIRE2 AMER1 MYCBP2 PRAG1 RUSC2 NEDD4 ANLN NHS USP4 BOD1L1 MAP4K4 ARHGAP21 AGAP1 PAK5 RICTOR CEP192 RGS12 SIPA1L1 ISCU NINL MACF1 LRBA TMCC1 | 1.50e-05 | 1102 | 190 | 26 | int:YWHAH |
| Interaction | SWSAP1 interactions | 1.57e-05 | 34 | 190 | 5 | int:SWSAP1 | |
| Interaction | FER1L4 interactions | 1.62e-05 | 6 | 190 | 3 | int:FER1L4 | |
| Interaction | FN3KRP interactions | 1.75e-05 | 58 | 190 | 6 | int:FN3KRP | |
| Interaction | MACF1 interactions | MYCBP2 CUL7 RNF43 BRWD3 ANLN FGD5 HERC2 OBSL1 KIF20A MACF1 LRBA | 2.37e-05 | 247 | 190 | 11 | int:MACF1 |
| Interaction | KIFC3 interactions | KRT26 CWF19L2 BARD1 NEDD4 ZGPAT ANLN NHS HERC2 KRT14 FANCM KIF20A | 2.85e-05 | 252 | 190 | 11 | int:KIFC3 |
| Interaction | LZTS2 interactions | CWF19L2 BRPF3 BIRC6 RNF43 TRIM66 ZGPAT BRCA2 ANLN AGAP1 CEP85 PAK5 CEP192 SIPA1L1 TTLL4 KLHL15 NINL | 2.96e-05 | 512 | 190 | 16 | int:LZTS2 |
| Interaction | YWHAB interactions | PABIR1 TET2 SYNRG SPIRE2 MYCBP2 CUL7 RNF43 RUSC2 NEDD4 ANLN NHS USP4 ARHGAP21 DYNC1H1 AGAP1 PAK5 RICTOR CEP192 TRAPPC8 RGS12 SIPA1L1 NINL MACF1 TMCC1 | 3.12e-05 | 1014 | 190 | 24 | int:YWHAB |
| Interaction | GIGYF1 interactions | 4.77e-05 | 177 | 190 | 9 | int:GIGYF1 | |
| Interaction | YWHAQ interactions | PABIR1 TET2 SYNRG SPIRE2 MYCBP2 CUL7 RNF43 RUSC2 NEDD4 ANLN NHS FGD5 GCN1 ARHGAP21 DYNC1H1 AGAP1 PAK5 OBSL1 RICTOR CEP192 RGS12 SIPA1L1 MACF1 LRBA TMCC1 | 5.35e-05 | 1118 | 190 | 25 | int:YWHAQ |
| Interaction | FAM83H interactions | 5.86e-05 | 141 | 190 | 8 | int:FAM83H | |
| Interaction | PLEC interactions | TET2 CUL7 BRCA2 ANLN USP4 FGD5 HERC2 KRT14 PAK5 OBSL1 RICTOR FANCM KIF20A MACF1 | 6.10e-05 | 430 | 190 | 14 | int:PLEC |
| Interaction | PHLDB2 interactions | 6.47e-05 | 143 | 190 | 8 | int:PHLDB2 | |
| Interaction | KRT6C interactions | 8.20e-05 | 76 | 190 | 6 | int:KRT6C | |
| Interaction | PRPF19 interactions | CWF19L2 ERCC5 CUL7 ANLN USP4 GCN1 DYNC1H1 SEC13 PHRF1 FNBP4 OBSL1 CEP192 KIF20A NINL | 9.88e-05 | 450 | 190 | 14 | int:PRPF19 |
| Interaction | YWHAZ interactions | PABIR1 TET2 SYNRG SPIRE2 MYCBP2 BARD1 CUL7 RUSC2 NEDD4 ANLN NHS HERC2 ARHGAP21 DYNC1H1 VDAC2 AGAP1 PAK5 OBSL1 RICTOR CEP192 RGS12 TRIM7 SIPA1L1 ISCU LPIN2 MACF1 TMCC1 | 1.17e-04 | 1319 | 190 | 27 | int:YWHAZ |
| Interaction | DES interactions | 1.30e-04 | 158 | 190 | 8 | int:DES | |
| Interaction | YWHAE interactions | PABIR1 TET2 SYNRG SPIRE2 MYCBP2 CUL7 PRAG1 RNF43 RUSC2 NEDD4 ANLN NHS FGD5 ARHGAP21 DYNC1H1 AGAP1 PAK5 OBSL1 RICTOR RGS12 SIPA1L1 ISCU LPIN2 MACF1 LRBA TMCC1 | 1.32e-04 | 1256 | 190 | 26 | int:YWHAE |
| GeneFamily | ArfGAPs | 4.99e-06 | 33 | 139 | 5 | 395 | |
| GeneFamily | X-linked mental retardation|Rho GTPase activating proteins|BAR-PH domain containing | 7.37e-06 | 17 | 139 | 4 | 1291 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 3.10e-05 | 206 | 139 | 9 | 682 | |
| GeneFamily | WD repeat domain containing | 9.61e-04 | 262 | 139 | 8 | 362 | |
| GeneFamily | Diacylglycerol O-acyltransferase 2 family | 1.59e-03 | 8 | 139 | 2 | 1235 | |
| GeneFamily | Cullins | 1.59e-03 | 8 | 139 | 2 | 1032 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.67e-03 | 66 | 139 | 4 | 722 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 2.04e-03 | 9 | 139 | 2 | 1234 | |
| GeneFamily | Zinc fingers C2H2-type|Sp transcription factors | 2.04e-03 | 9 | 139 | 2 | 755 | |
| GeneFamily | CD molecules|Toll like receptors | 2.54e-03 | 10 | 139 | 2 | 948 | |
| GeneFamily | Solute carriers | SLC5A6 SLC12A6 SLC17A4 SLC6A2 SLC17A5 SLC12A3 SLC12A4 SLC2A13 SLC12A7 | 3.51e-03 | 395 | 139 | 9 | 752 |
| Coexpression | GSE16385_UNTREATED_VS_12H_ROSIGLITAZONE_IL4_TREATED_MACROPHAGE_DN | MKKS CWF19L2 MYCBP2 GPR135 ADAMTS9 GMNN PREX2 P2RX2 TLR5 CIPC ELP4 | 3.00e-07 | 200 | 193 | 11 | M7913 |
| Coexpression | THEODOROU_MAMMARY_TUMORIGENESIS | 7.40e-06 | 37 | 193 | 5 | MM1121 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 7.98e-06 | 180 | 193 | 9 | M8239 | |
| Coexpression | GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_6H_ACT_CD4_TCELL_DN | 1.58e-05 | 196 | 193 | 9 | M4218 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_DN | 1.77e-05 | 44 | 193 | 5 | MM485 | |
| Coexpression | GSE21670_UNTREATED_VS_TGFB_TREATED_STAT3_KO_CD4_TCELL_UP | 1.78e-05 | 199 | 193 | 9 | M7474 | |
| Coexpression | BILD_CTNNB1_ONCOGENIC_SIGNATURE | 2.62e-05 | 79 | 193 | 6 | M7102 | |
| Coexpression | GSE7509_UNSTIM_VS_FCGRIIB_STIM_MONOCYTE_DN | 3.34e-05 | 166 | 193 | 8 | M6826 | |
| Coexpression | GSE7568_CTRL_VS_3H_TGFB_TREATED_MACROPHAGES_WITH_IL4_AND_DEXAMETHASONE_DN | 3.49e-05 | 167 | 193 | 8 | M361 | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.96e-09 | 137 | 195 | 9 | 4dcb15de821439011df1bb0bbd7682d674bd725d | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.96e-09 | 137 | 195 | 9 | c05ceeb7b483324604cb3f647d2da2b3786071b1 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.34e-07 | 185 | 195 | 9 | 08fad1e3c3cc5f1c3eb6629a49c094b628e75a92 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.83e-07 | 192 | 195 | 9 | 3abee376c37c3646da33ac381aa63d50a01607a6 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN2(Gad1Gad2)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 8.29e-07 | 169 | 195 | 8 | c135d7ae0490d0024e0f4bd8c4ad42f6674a61da | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-3_VIP_SSTR1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.17e-06 | 177 | 195 | 8 | fdab7b7ddfb06f913b8224c0c80574dc3cf4cbd4 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.28e-06 | 179 | 195 | 8 | 97ba67a856680f24846244c0b92c886cc0e79537 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.45e-06 | 182 | 195 | 8 | 7dc61e901428cea04f00ebb0939a44d21a6145c6 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-6_VIP_RGS16|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.45e-06 | 182 | 195 | 8 | 724c33ad2fb525cbcfa5efa3362675eb42a5636d | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.45e-06 | 182 | 195 | 8 | 420a8fd30543e37a66ba0786215d056d308660d0 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.51e-06 | 183 | 195 | 8 | 5e361be3ae3fe05098968e58427630127bd12675 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.51e-06 | 183 | 195 | 8 | e3ffef2b57dc5b96466dccc9cd54ba326ccf378a | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.57e-06 | 184 | 195 | 8 | e8238fe58f94b4f5700ab7f343fb06ea61e899a9 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.64e-06 | 185 | 195 | 8 | 027020754dbf71b0034791f9a34ae795e3b85f81 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|World / Lineage, Cell type, age group and donor | 1.77e-06 | 187 | 195 | 8 | 81cc8435b2704a9a8287b3f54acaae0f11dd4ac7 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.77e-06 | 187 | 195 | 8 | 9d77ca45f7563bd6f2a0c1be5d99d93ad30983f7 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.77e-06 | 187 | 195 | 8 | 02105c82a9ba79d2f19e002188377fc3440770c2 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.00e-06 | 190 | 195 | 8 | 989d4eefd22d66ecb857836f8fdbcf41e3047f84 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.00e-06 | 190 | 195 | 8 | 63018acb7ad80415e861643162abdc2e55968ee4 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.16e-06 | 192 | 195 | 8 | 6a252e298f8a454623fa9c1c893a7a45a886d694 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Serpinf1-Serpinf1_Aqp5_Vip|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.35e-06 | 136 | 195 | 7 | 8f5682422ba0b477c1e0700212948457f106cb10 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Synpr|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 2.72e-06 | 139 | 195 | 7 | 408bc31aa5e1c2b379f79198fe8b5411f8d7bd08 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 2.92e-06 | 200 | 195 | 8 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.76e-06 | 146 | 195 | 7 | 1bf67a9416f52198931b912a31be4bab09fefd19 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Lect1_Oxtr|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.30e-06 | 149 | 195 | 7 | 10ffd0051fb027bbebc662ca602c80d89bbf99c6 | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 5.58e-06 | 155 | 195 | 7 | 105d59d8a1bb8cb37eef2c1767d737b2108ac7c5 | |
| ToppCell | TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-7|TCGA-Liver / Sample_Type by Project: Shred V9 | 6.60e-06 | 159 | 195 | 7 | 70288df54adab167c0f50675128619299077db11 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Chat_Htr1f|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.06e-05 | 171 | 195 | 7 | f9ae7964a3740f559431125c17c660549798cccc | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-6_VIP_RGS16|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.10e-05 | 172 | 195 | 7 | 8b396d1e9173da104d467e42286379fe07cee257 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.14e-05 | 173 | 195 | 7 | afa6bb19df52541d8d17cbfac9cbdd18a5f3632d | |
| ToppCell | severe_influenza-Plasmablast|World / disease group, cell group and cell class (v2) | 1.23e-05 | 175 | 195 | 7 | e6d6c44510d5dc4eb0bae820125e42366f7a4e74 | |
| ToppCell | Influenza_Severe-Plasmablast|World / Disease group and Cell class | 1.23e-05 | 175 | 195 | 7 | 14df8fc6f6beae1be7b7bd5837546d1ac1239a6f | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.43e-05 | 179 | 195 | 7 | 815b959ce8721c5ded70c0ca6e318dafc691746e | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.43e-05 | 179 | 195 | 7 | 87f608b137aae34572b150492a83a3a127cff40b | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-6_VIP_VIP|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.48e-05 | 180 | 195 | 7 | c6030e725e3d86d5d74a1676330c77ffeceb324f | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.53e-05 | 181 | 195 | 7 | 2f3d04d22d4ac016e61709ea5af3d48885c946c4 | |
| ToppCell | Control-Epithelial_cells-Airway_club|Control / group, cell type (main and fine annotations) | 1.53e-05 | 181 | 195 | 7 | c755d23dd9aabc717dc73e2b3fa99a1f751e6507 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.59e-05 | 182 | 195 | 7 | b54ae650c04dfd0759c5f5e752b9bf684dd36516 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.77e-05 | 185 | 195 | 7 | 98b8ee42b89d97e4c9db01740e0c193503c68f2c | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_VIP_PRSS8|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.77e-05 | 185 | 195 | 7 | 4c42bd3cd72f91f4d4ebb849069a03761a2cd662 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-4_VIP_CHRNA2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.77e-05 | 185 | 195 | 7 | 3189e91fe26df59bd605d2b6223ceb1779daf0b8 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.77e-05 | 185 | 195 | 7 | 16e9ccea0e3b95d90dc48ef74206c805681dac0b | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.77e-05 | 185 | 195 | 7 | 51dfe6ac7df8b330343b37e3bee71e5c65267189 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.77e-05 | 185 | 195 | 7 | 79cff4f3c6ae8e5ea60e8eae082b9275f2679ee9 | |
| ToppCell | COVID-19-Fibroblasts-Pericytes|COVID-19 / group, cell type (main and fine annotations) | 1.77e-05 | 185 | 195 | 7 | 4905adaeeffd353e089578e5ea614437dbe794e6 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.77e-05 | 185 | 195 | 7 | a8c02cec3c414f3a0da9f2d6d28ce563b0030705 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.83e-05 | 186 | 195 | 7 | f28d72b47624b69a580b4429e2be560a26898591 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T2|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.89e-05 | 187 | 195 | 7 | f3e37c18ac6471c7992609bbddfa4975571c815c | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.89e-05 | 187 | 195 | 7 | f5a202d5f8eb57b57d80815ce98774e04c387383 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.03e-05 | 189 | 195 | 7 | b6b4da51bc7f2c13a2f940540fdc61027d084835 | |
| ToppCell | Mesenchymal-pericyte_cell|World / Lineage, Cell type, age group and donor | 2.03e-05 | 189 | 195 | 7 | d7ed96add29f219183c802895fbff519b627f635 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1-Pericyte|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.10e-05 | 190 | 195 | 7 | 4eb92aef1ee868f4537483d19014d947b7684612 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.10e-05 | 190 | 195 | 7 | 7be4341e2909101d756f14031c21e705eb45e69a | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.17e-05 | 191 | 195 | 7 | 1c1d13144259b998d4a0e85142f7afef2ef1e63f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.17e-05 | 191 | 195 | 7 | 3c464645d0e7e423f791bd63bf5bcf11f6b590d3 | |
| ToppCell | COVID-19-lung-AT2|lung / Disease (COVID-19 only), tissue and cell type | 2.17e-05 | 191 | 195 | 7 | 276455a64c2c3503d5048615762eb2ee37f0ac70 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.24e-05 | 192 | 195 | 7 | bf1943715085c4124b1675888b0615c9500ec888 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.24e-05 | 192 | 195 | 7 | 025fac36b862f9ca7f96fb4a1946c44ba7cbc382 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.24e-05 | 192 | 195 | 7 | 67d6230e32d446dcb12047fae2c3f1faa80dd720 | |
| ToppCell | RV-08._Macrophage|RV / Chamber and Cluster_Paper | 2.32e-05 | 193 | 195 | 7 | 12bf98a280f87e4d8f0c6887dfc855da72e47ac1 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Fam19a1_Pax6|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.34e-05 | 130 | 195 | 6 | 60e28d452d0e2af768459ba8dbe998117c94a251 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.56e-05 | 196 | 195 | 7 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | Influenza-Influenza_Severe-Lymphocyte-B-Plasmablast|Influenza_Severe / Disease, condition lineage and cell class | 2.64e-05 | 197 | 195 | 7 | 9108edafbf5744ed65f556bcbbf819a9b71176a9 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 2.64e-05 | 197 | 195 | 7 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.91e-05 | 200 | 195 | 7 | d0167f96314be78b6d867bbcc6e4396071d931b8 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.91e-05 | 200 | 195 | 7 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Neuronal-Inhibitory-iA|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.91e-05 | 200 | 195 | 7 | 5ef4a3dc18a44292184a59ced916183c0699b01e | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-QPCT|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.91e-05 | 200 | 195 | 7 | 85e1b598c9f3976215b20eeda077d8aab621cce6 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-PCDH20-L1-2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.91e-05 | 200 | 195 | 7 | 1d67c5d2c617749b521e70879950dea2c9d076d6 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-SST|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.91e-05 | 200 | 195 | 7 | 53d5e427f0cbf5cf0b63efe4ec01da302f555704 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-QPCT-L2-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.91e-05 | 200 | 195 | 7 | 2f2c5331511a924fa0bb1689f4c81641d754c9b9 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-PCDH20|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.91e-05 | 200 | 195 | 7 | 26c7f2b0afe9e50f2a5c43918ad8e91d7553b72c | |
| ToppCell | Neuronal-Inhibitory|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.91e-05 | 200 | 195 | 7 | 9ff8647e2de0b538e15929dca88ebb20ff7ab043 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-OPRM1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.91e-05 | 200 | 195 | 7 | 559cf4001a3f985c8357f0102b34fab2e34d2a04 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-OPRM1-L1-4|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.91e-05 | 200 | 195 | 7 | cc0d639d38eb99414ba8b54d3000701962394465 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.91e-05 | 200 | 195 | 7 | 75649534a98bc738fca62d071de0978dc61eb24f | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Serpinf1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 5.04e-05 | 149 | 195 | 6 | 5293c50b3fb41b1edaf9a97354899bd13770078c | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D122|Adult / Lineage, Cell type, age group and donor | 6.74e-05 | 157 | 195 | 6 | 31d1bd9138c60e8485664ec4144f987226e3eef9 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 7.22e-05 | 159 | 195 | 6 | 7f29f9dcf25ffa1822b137c571e9ac16defc6292 | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 7.48e-05 | 160 | 195 | 6 | 29c9b4770d0e73d59cffc7937b179484c76b6dcc | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|RV / Chamber and Cluster_Paper | 7.74e-05 | 161 | 195 | 6 | 47b3b7662cbb671ccc086dc0a0cabd65f63eb5a1 | |
| ToppCell | Hippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 7.74e-05 | 161 | 195 | 6 | b81b346309f3facbfbebd91cae4c5b33c7bd24ef | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Lsp1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.29e-05 | 163 | 195 | 6 | bba830a302919c8b33f914a8839877fc21dd28a0 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.29e-05 | 163 | 195 | 6 | 7864e966c228282b4b63c43164dba3faba21026d | |
| ToppCell | Frontal_cortex|World / BrainAtlas - Mouse McCarroll V32 | 8.57e-05 | 164 | 195 | 6 | e09291711abf8680e78170328313719092b0142f | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.57e-05 | 164 | 195 | 6 | 08819970174a3eb4eee8e1e675075828665b845e | |
| ToppCell | RSV-Healthy-6|Healthy / Virus stimulation, Condition and Cluster | 8.57e-05 | 164 | 195 | 6 | 1b9c5a6dc4e09b90f92e98b81a5ee620f8479cc7 | |
| ToppCell | RSV-Healthy-6|RSV / Virus stimulation, Condition and Cluster | 8.57e-05 | 164 | 195 | 6 | ab312b8c2f828ea7331f2a340c4df81587a23b5c | |
| ToppCell | mild_COVID-19_(asymptomatic)-Plasmablast|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 9.16e-05 | 166 | 195 | 6 | 0cc3b9681bc000a1b00d3b60f79f16eea1c2e2e1 | |
| ToppCell | P15-Epithelial-airway_epithelial_cell-ciliated_cell_of_airway|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 9.47e-05 | 167 | 195 | 6 | 5c3d0763f73628c71c71f9883556bb4f1639f3cc | |
| ToppCell | mild_COVID-19_(asymptomatic)-Plasmablast|World / disease group, cell group and cell class (v2) | 9.47e-05 | 167 | 195 | 6 | f26ae4de4804a3486502e3df37eabf3dfca688f5 | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 9.47e-05 | 167 | 195 | 6 | 9a84f45345c75f2c8ff38a04245aadee2a26a240 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D231|Adult / Lineage, Cell type, age group and donor | 1.04e-04 | 170 | 195 | 6 | 269dee5abca9f6aa079f116f0d8f1d198604d9d4 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.04e-04 | 170 | 195 | 6 | a2c738e441ced90eeeb1fcc6ca3269b918aaa298 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.04e-04 | 170 | 195 | 6 | e20568c8f3f17d94de78229617eb2f7e4c5af2bc | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-4_VIP_CHRNA2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.04e-04 | 170 | 195 | 6 | 28e22f9ef58423acc0fb8de1aff958b116dd33e9 | |
| ToppCell | Control-Fibroblasts-Pericytes|Control / group, cell type (main and fine annotations) | 1.08e-04 | 171 | 195 | 6 | 080003f698f867935c2bfc55d241d3650f45a0ab | |
| ToppCell | LV-13._Vascular_Smooth_Muscle|LV / Chamber and Cluster_Paper | 1.08e-04 | 171 | 195 | 6 | e99ecae66530d1ae09330cee408c8f3950b87e67 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW23-Mesenchymal-Unfolded_protein_responsible_cell|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 1.08e-04 | 107 | 195 | 5 | 7fee0193ee02e9cc62f506660ea7ec23fb4d0c84 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.11e-04 | 172 | 195 | 6 | eeed177a03c116e9815a8e086d24efc9643b16a4 | |
| Disease | cerebral palsy (implicated_via_orthology) | 2.44e-09 | 10 | 188 | 5 | DOID:1969 (implicated_via_orthology) | |
| Disease | Autistic Disorder | ACADSB PECAM1 CUL7 MBD4 AGAP1 CACNA1C CNTN4 HTR1D ATP10A IGF1 | 7.41e-06 | 261 | 188 | 10 | C0004352 |
| Disease | hair color | TET2 SPIRE2 ALX4 SEMA6D KCNH1 BANP HERC2 RAD51B CNTN4 CDK5RAP1 | 3.35e-05 | 311 | 188 | 10 | EFO_0003924 |
| Disease | Malignant neoplasm of breast | ARHGEF38 BARD1 NEDD4 BRCA2 KCNH1 NHS BOD1L1 OXSM FGD5 HERC2 RAD51B KRT14 TRAPPC8 ADAM12 IGF1 SIPA1L1 MACF1 MAP3K13 LRBA | 6.12e-05 | 1074 | 188 | 19 | C0006142 |
| Disease | epilepsy (implicated_via_orthology) | 8.79e-05 | 163 | 188 | 7 | DOID:1826 (implicated_via_orthology) | |
| Disease | Osteopenia | 1.09e-04 | 15 | 188 | 3 | C0029453 | |
| Disease | 3-M syndrome | 1.21e-04 | 3 | 188 | 2 | cv:C1848862 | |
| Disease | 3-M syndrome (is_implicated_in) | 1.21e-04 | 3 | 188 | 2 | DOID:0060241 (is_implicated_in) | |
| Disease | cortical surface area measurement | TET2 SPIRE2 PCNX3 MYCBP2 GPR135 TTC34 ALX4 SP8 ADAMTS9 NFIX PKD1 MAP4K4 ARHGAP21 AGAP1 RAD51B HTR1D KHNYN ADAM12 IGF1 MACF1 PAX7 | 1.45e-04 | 1345 | 188 | 21 | EFO_0010736 |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 1.94e-04 | 45 | 188 | 4 | DOID:3748 (is_implicated_in) | |
| Disease | uveal melanoma (is_implicated_in) | 2.40e-04 | 4 | 188 | 2 | DOID:6039 (is_implicated_in) | |
| Disease | Bipolar Disorder | NEDD4 SP8 BRCA2 NFIX SLC12A6 CACNA1C CNTN4 GRIK1 SLC6A2 IGF1 CTLA4 | 2.61e-04 | 477 | 188 | 11 | C0005586 |
| Disease | unipolar depression, memory performance, cognitive function measurement | 2.68e-04 | 20 | 188 | 3 | EFO_0003761, EFO_0004874, EFO_0008354 | |
| Disease | COVID-19 (is_implicated_in) | 3.11e-04 | 21 | 188 | 3 | DOID:0080600 (is_implicated_in) | |
| Disease | lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma | 3.40e-04 | 52 | 188 | 4 | EFO_0000305, EFO_0000571, EFO_0000708, EFO_0001071, EFO_0001075, EFO_0001663, EFO_1000650, EFO_1001515, EFO_1001516, MONDO_0005575 | |
| Disease | Libman-Sacks Disease | 5.18e-04 | 58 | 188 | 4 | C0242380 | |
| Disease | mitochondrial myopathy (implicated_via_orthology) | 5.96e-04 | 6 | 188 | 2 | DOID:699 (implicated_via_orthology) | |
| Disease | age at diagnosis, substance-related disorder | 5.96e-04 | 6 | 188 | 2 | EFO_0004918, MONDO_0002494 | |
| Disease | malaria (is_marker_for) | 5.96e-04 | 6 | 188 | 2 | DOID:12365 (is_marker_for) | |
| Disease | cortical thickness | A2M SPIRE2 GALK2 MYCBP2 TTC34 ALX4 SP8 ADAMTS9 NFIX PKD1 ARHGAP21 AGAP1 RAD51B HTR1D ADAM12 MACF1 PAX7 | 8.08e-04 | 1113 | 188 | 17 | EFO_0004840 |
| Disease | waist-hip ratio | TET2 MYCBP2 BIRC6 CFAP65 TRIM66 SP8 ZNRF3 ADAMTS9 NFIX SEMA3B PKD1 ARHGAP21 RAD51B SLC17A4 CEP192 TRIM7 CEMIP IGF1 | 8.93e-04 | 1226 | 188 | 18 | EFO_0004343 |
| Disease | alpha-2-macroglobulin measurement | 1.10e-03 | 8 | 188 | 2 | EFO_0020138 | |
| Disease | Lupus Erythematosus, Systemic | 1.11e-03 | 71 | 188 | 4 | C0024141 | |
| Disease | disease recurrence, unipolar depression, bipolar disorder, schizophrenia, sex interaction measurement | 1.21e-03 | 33 | 188 | 3 | EFO_0003761, EFO_0004952, EFO_0008343, MONDO_0004985, MONDO_0005090 | |
| Disease | melanoma (is_implicated_in) | 1.32e-03 | 34 | 188 | 3 | DOID:1909 (is_implicated_in) | |
| Disease | Abnormality of refraction | SMG1 BIRC6 NEDD4 ZGPAT ADAMTS9 NFIX PZP PHRF1 COX10 GRIK1 IGF1 ISCU | 1.34e-03 | 673 | 188 | 12 | HP_0000539 |
| Disease | influenza A severity measurement | 1.41e-03 | 9 | 188 | 2 | EFO_0007743 | |
| Disease | Gastrointestinal Hemorrhage | 1.41e-03 | 9 | 188 | 2 | C0017181 | |
| Disease | interleukin 1 receptor-like 2 measurement | 1.41e-03 | 9 | 188 | 2 | EFO_0008169 | |
| Disease | neuroimaging measurement | SPIRE2 TTC34 ALX4 SP8 ZNRF3 NFIX PKD1 AGAP1 RAD51B HTR1D PAK5 METTL4 POM121C NINL MACF1 PAX7 | 1.42e-03 | 1069 | 188 | 16 | EFO_0004346 |
| Disease | Inherited focal segmental glomerulosclerosis | 1.76e-03 | 10 | 188 | 2 | cv:CN327126 | |
| Disease | Focal segmental glomerulosclerosis | 1.76e-03 | 10 | 188 | 2 | cv:C0017668 | |
| Disease | urate measurement | PCNX3 BIRC6 GJA10 HEATR5B TECPR1 SLC17A4 GRIK1 CEMIP SMU1 LRP2 NINL TMF1 SENP2 PAX7 | 1.87e-03 | 895 | 188 | 14 | EFO_0004531 |
| Disease | cigarettes per day measurement | 2.08e-03 | 438 | 188 | 9 | EFO_0006525 | |
| Disease | Systemic lupus erythematosus | 2.14e-03 | 11 | 188 | 2 | cv:C0024141 | |
| Disease | Hereditary Nephrotic Syndromes, Autosomal Dominant | 2.14e-03 | 11 | 188 | 2 | cv:CN043612 | |
| Disease | X-18913 measurement | 2.14e-03 | 11 | 188 | 2 | EFO_0800795 | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 2.27e-03 | 41 | 188 | 3 | C0496956 | |
| Disease | Breast adenocarcinoma | 2.27e-03 | 41 | 188 | 3 | C0858252 | |
| Disease | Kidney Diseases | 2.45e-03 | 88 | 188 | 4 | C0022658 | |
| Disease | autoimmune thyroiditis (is_implicated_in) | 2.56e-03 | 12 | 188 | 2 | DOID:7188 (is_implicated_in) | |
| Disease | polycystic ovary syndrome (is_marker_for) | 2.56e-03 | 12 | 188 | 2 | DOID:11612 (is_marker_for) | |
| Disease | N-acetyl-2-aminooctanoate measurement | 2.56e-03 | 12 | 188 | 2 | EFO_0800567 | |
| Disease | Seizures | 2.82e-03 | 218 | 188 | 6 | C0036572 | |
| Disease | Familial idiopathic steroid-resistant nephrotic syndrome | 3.01e-03 | 13 | 188 | 2 | cv:C4273714 | |
| Disease | Benign tumor of pancreas | 3.01e-03 | 13 | 188 | 2 | C0347284 | |
| Disease | Graves ophthalmopathy (is_marker_for) | 3.01e-03 | 13 | 188 | 2 | DOID:0081120 (is_marker_for) | |
| Disease | body weight | TET2 ARHGEF38 TRIM66 SP8 ZGPAT SEMA6D ANLN PKD1 AGAP1 CACNA1C PAK5 GRID2 CEP192 POM121C CRB1 LMX1B SP9 | 3.02e-03 | 1261 | 188 | 17 | EFO_0004338 |
| Disease | colorectal cancer (is_marker_for) | 3.40e-03 | 157 | 188 | 5 | DOID:9256 (is_marker_for) | |
| Disease | alcohol use disorder measurement, alcohol consumption measurement | 3.49e-03 | 97 | 188 | 4 | EFO_0007878, EFO_0009458 | |
| Disease | upper face morphology measurement | 3.49e-03 | 97 | 188 | 4 | EFO_0010949 | |
| Disease | Metabolic Bone Disorder | 3.49e-03 | 14 | 188 | 2 | C0005944 | |
| Disease | membranous glomerulonephritis (biomarker_via_orthology) | 3.49e-03 | 14 | 188 | 2 | DOID:10976 (biomarker_via_orthology) | |
| Disease | Hereditary Breast and Ovarian Cancer Syndrome | 3.49e-03 | 14 | 188 | 2 | C0677776 | |
| Disease | neuroticism measurement, cognitive function measurement | TET2 BIRC6 SEMA6D NFIX USP4 AGAP1 CACNA1C HTR1D VAC14 SIPA1L1 | 3.56e-03 | 566 | 188 | 10 | EFO_0007660, EFO_0008354 |
| Disease | schizophrenia, anorexia nervosa | 3.57e-03 | 48 | 188 | 3 | MONDO_0005090, MONDO_0005351 | |
| Disease | lung adenocarcinoma (is_implicated_in) | 3.78e-03 | 49 | 188 | 3 | DOID:3910 (is_implicated_in) | |
| Disease | reading and spelling ability | 4.31e-03 | 166 | 188 | 5 | EFO_0005301 | |
| Disease | suntan | 4.32e-03 | 103 | 188 | 4 | EFO_0004279 | |
| Disease | Seizures, Focal | 4.47e-03 | 104 | 188 | 4 | C0751495 | |
| Disease | C-reactive protein measurement | CWF19L2 PRAG1 USP44 ZGPAT SLC5A6 PKD1 MAP4K4 GCN1 ARHGAP21 SGIP1 RICTOR CEP192 LMX1B SP9 MACF1 KRTAP11-1 | 4.64e-03 | 1206 | 188 | 16 | EFO_0004458 |
| Disease | PR interval | PCNX3 MYCBP2 METTL4 SIPA1L1 LPIN2 MACF1 SENP2 KRTAP11-1 SLC12A7 | 4.65e-03 | 495 | 188 | 9 | EFO_0004462 |
| Disease | monoclonal gammopathy | 4.72e-03 | 53 | 188 | 3 | EFO_0000203 | |
| Disease | Hypotension | 4.72e-03 | 53 | 188 | 3 | C0020649 | |
| Disease | prostate carcinoma | TET2 IFT140 GPATCH8 RNF43 NEDD4 SP8 ZGPAT ANLN GPC5 CRAMP1 RAD51B LRRC8B AGAP7P | 4.85e-03 | 891 | 188 | 13 | EFO_0001663 |
| Disease | Peripheral Nervous System Diseases | 4.97e-03 | 54 | 188 | 3 | C4721453 | |
| Disease | glycochenodeoxycholate measurement | 5.16e-03 | 17 | 188 | 2 | EFO_0010490 | |
| Disease | Hypogammaglobulinemia | 5.16e-03 | 17 | 188 | 2 | C0086438 | |
| Disease | perinatal necrotizing enterocolitis (biomarker_via_orthology) | 5.16e-03 | 17 | 188 | 2 | DOID:8677 (biomarker_via_orthology) | |
| Disease | Epilepsy | 5.28e-03 | 109 | 188 | 4 | C0014544 | |
| Disease | aspartate aminotransferase measurement | WWC3 STRA8 PRAG1 BIRC6 CD163 ZGPAT ADAMTS9 GCN1 AGAP1 POM121C SLC17A5 CTLA4 LRBA | 5.46e-03 | 904 | 188 | 13 | EFO_0004736 |
| Disease | intraocular pressure measurement | 5.56e-03 | 509 | 188 | 9 | EFO_0004695 | |
| Disease | Bone marrow hypocellularity | 5.78e-03 | 18 | 188 | 2 | C1855710 | |
| Disease | peritonsillar abscess | 5.78e-03 | 18 | 188 | 2 | EFO_0007429 | |
| Disease | response to tenofovir, creatinine clearance measurement | 5.81e-03 | 112 | 188 | 4 | EFO_0007934, EFO_0009279 | |
| Disease | response to efavirenz, virologic response measurement | 6.07e-03 | 58 | 188 | 3 | EFO_0006904, EFO_0006906 | |
| Disease | hepatocellular carcinoma (is_implicated_in) | 6.19e-03 | 181 | 188 | 5 | DOID:684 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SEASDSVSSCGQAGS | 181 | Q8N9N5 | |
| SGASSVTDFLSVSGA | 341 | Q9H161 | |
| TGLGDSICFSPSISS | 346 | Q96P64 | |
| SEGFFLIGSTTSRCE | 141 | P04003 | |
| SSTDSASSCFKGGRE | 176 | P58512 | |
| LASGSSVSFVGASGC | 221 | Q03989 | |
| AISSDTGLGDSVCSS | 491 | Q9UPQ3 | |
| LGDSICFSPGISSTT | 416 | Q5VTM2 | |
| NGKVSSCTAAEGSFT | 1541 | Q9NR09 | |
| SCTAAEGSFTSLTGL | 1546 | Q9NR09 | |
| LASGSLTESECFGSL | 261 | Q99728 | |
| IGDSSSSLSGTCGKF | 686 | Q9NXL2 | |
| SSLSGTCGKFETNGT | 691 | Q9NXL2 | |
| DSGSSGSRNSSCLDF | 446 | Q969M2 | |
| NSTSGTTLSTDLECG | 886 | P39086 | |
| TCIATNHFGTASSTG | 476 | Q8IWV2 | |
| LTSVGTGLASCAANS | 191 | Q12887 | |
| TESGSDSECSLGLSG | 1006 | Q9ULD4 | |
| ISCSSFSSGGMFITT | 321 | Q6RI45 | |
| SGELGSSLSSESTCG | 1606 | Q6RI45 | |
| VGSFCLSEAGAGSDS | 171 | P45954 | |
| VTSLKSFDSLTGCGD | 316 | Q5JTC6 | |
| RGYSDSAVSLSTCSG | 126 | O43184 | |
| SLDDSGSCLSGSQRT | 406 | P35368 | |
| TLTCFPGATSTVAAG | 21 | Q8WUJ3 | |
| GFCSSASTLEGLSVS | 1281 | A7MBM2 | |
| SCLTSGCSSIGSLAA | 616 | O60312 | |
| CLSEDAGLGISSTAS | 771 | P01023 | |
| TGLGDSICFSPSISS | 346 | Q5VW22 | |
| SLSEGTSGSSCVIAA | 281 | O15315 | |
| FCLSEDAGLGISSTA | 776 | P20742 | |
| KTFGCGSAIASSSLA | 91 | Q9H1K1 | |
| SGAVSCSSSFGSVEE | 216 | Q2M2E3 | |
| GGLDSATSISASCSQ | 411 | P23759 | |
| SSFSCTLEGISSGGS | 41 | Q7Z3Y9 | |
| EGTDGASLAGTSSCS | 466 | Q9HCC9 | |
| TGTLHSCSLTGSVAE | 386 | Q8N635 | |
| LGLADSGCVSFTADS | 1601 | O75147 | |
| GTSGCSKESLAYSES | 241 | Q9P286 | |
| STACTTGAHAVGDSF | 206 | Q9NWU1 | |
| SGTTVTSVVGFSCDG | 871 | O95819 | |
| VALFCTTLSGDTSDT | 241 | Q9NPJ1 | |
| GVTFSGSSSVCATSG | 511 | Q9NSB2 | |
| GSSSVCATSGVLASC | 516 | Q9NSB2 | |
| SGKLDFCSALSSQGS | 326 | Q14938 | |
| ICSGSLSNFSTSDNG | 146 | P46934 | |
| DLDCASSSGSDLSGF | 11 | Q92886 | |
| STLDTTGAGCAVATE | 541 | P78333 | |
| CGSSHSAALTSSGEL | 3106 | O95714 | |
| SVSSSRFSSGGACGL | 51 | P02533 | |
| GTFTCIASNAAGEAT | 366 | Q9P244 | |
| GTACLSKFSSASGAS | 231 | Q9NQW6 | |
| VNSGGSCLSASTVAI | 86 | Q6ZU64 | |
| DGSALEDSSTSGASC | 1781 | Q8IYD8 | |
| GSGSGTDFTLTISCL | 86 | A0A087WSZ0 | |
| LFGSTSSFCLISGSS | 196 | P08174 | |
| TTSGTTRLLSGHTCF | 351 | P08174 | |
| GSLTSLDSSVFCSEG | 16 | Q6PIU1 | |
| SCGTSVASSEGSEEL | 71 | Q6PEV8 | |
| NFSCASTSGVSGASA | 266 | Q6PEV8 | |
| TGATASCGLGSEFST | 241 | Q9UKJ3 | |
| SIGCTSAGSLQSLAD | 96 | O43424 | |
| GSSDSCFSGTDRETL | 296 | Q9H6A9 | |
| ASKSDSGTYICTAGI | 376 | P16284 | |
| SSSALVAQGSLCSGF | 391 | Q2TBE0 | |
| LVSSLGKGSACSSTD | 1606 | Q14999 | |
| GCSLTVRSGSHFSAV | 336 | Q4G0M1 | |
| DNLSLSCVIGSSGSF | 581 | Q6ZNL6 | |
| SSGLSSSSALVCCAG | 141 | Q01415 | |
| GASCSTFFGSEERTV | 946 | Q9P1Y6 | |
| AGESVDSLCFVVSGS | 611 | O95259 | |
| EIGLCSSTSVQAASG | 946 | P50851 | |
| EFGLVTTCGTGSSDF | 441 | A0A1B0GTW7 | |
| TTCGTGSSDFFCTGS | 446 | A0A1B0GTW7 | |
| DTLTTLCASSSGDDG | 1061 | Q92616 | |
| GSSFIEGSTTECDAA | 4356 | P98164 | |
| GVCVSSDTLDGNSSS | 236 | Q96E09 | |
| CSDGVSQEGSASSTK | 1576 | Q6R327 | |
| CTFSGFSLSTSGVGV | 41 | P01817 | |
| SSSGCSADIDSGKQS | 191 | Q6P9F7 | |
| QSACSDTSESSAAGG | 7341 | Q9UPN3 | |
| SAADFSGFGSTLATS | 891 | A8CG34 | |
| GGLAFSDACTSTSIT | 66 | Q9NZP5 | |
| FSGCRSESSLGTSHL | 781 | O43283 | |
| GAFANLCTESTGFSS | 116 | Q3SYC2 | |
| ATALTSVGVGSFLCD | 346 | Q9UBL9 | |
| CTGSEDSSEGFAISS | 1806 | Q8NFC6 | |
| RSCSISEDSGLSTAF | 416 | Q9P2N4 | |
| DRGTYECIATSSTGS | 1911 | Q6WRI0 | |
| STGFTCSESTEAAAI | 1541 | Q9P2D3 | |
| GGTSSAATAAVLSFS | 31 | Q8IZ08 | |
| EGFCSSIHDTSVSAG | 6 | Q96M94 | |
| STGACSVSRSSIDFL | 156 | Q6E213 | |
| SFTLTSGSACGSSVL | 361 | Q9Y426 | |
| SGSACGSSVLGSVTA | 366 | Q9Y426 | |
| SNSTEGETPCGSSFA | 1486 | Q13936 | |
| SANTCGIFSTASGKS | 1971 | P51587 | |
| SSSCGDTELLGQATL | 356 | O14523 | |
| SVADSGDTAIGTSCS | 51 | Q6P2H3 | |
| CSFSILSNSSVTGRG | 906 | Q96RY5 | |
| TCTLTGLRDASGVTF | 146 | P01876 | |
| TAHLITGSAGSSLCS | 241 | P28221 | |
| TGLGDSICFSPSISS | 346 | Q5VUJ5 | |
| SDAGACGETLSVTSE | 291 | O95243 | |
| GTSSSGCALESFGSA | 1001 | Q8TEP8 | |
| TTSQGATLDACSFGV | 4546 | Q14204 | |
| SSGASQCTGVLRDFS | 151 | O15037 | |
| GSGTDFTLTISCLQS | 86 | A0A0C4DH67 | |
| VTTTSTTDADCLGGI | 26 | Q8IUC1 | |
| TFLDDSICTGTSSGN | 96 | P16410 | |
| TFTSSATAGPETLCG | 41 | P05019 | |
| FLGSLSISSTPCDTF | 551 | Q8IW92 | |
| TCGSVAASTGSAVAT | 6 | Q96EB1 | |
| TGSLCEIATTLSFEG | 476 | P82279 | |
| SACFVTSSLGGTDKE | 36 | Q86VB7 | |
| SFFSTCGAGLQSLTG | 576 | Q9UHW9 | |
| SFFSTCGAGLQSLTG | 511 | Q9Y666 | |
| LSSAISSFCESGALV | 401 | Q9Y2C5 | |
| LTISTTLGGFCSSGF | 396 | Q9NRA2 | |
| GIASLRCSSSGSTIS | 571 | Q96RY7 | |
| PSTSSFCLGVSVAAS | 96 | Q13620 | |
| DSVSSSGVCAAFIAS | 51 | Q8N3J2 | |
| SGVCAAFIASDSSTK | 56 | Q8N3J2 | |
| RVHTCSAAGGFSTSD | 3766 | P98161 | |
| VSIFCSGDSSISFSA | 86 | Q8NGK6 | |
| IGTCAEGTVSSSTDA | 191 | O75496 | |
| AGECSLLAAAESSTS | 36 | Q96QE2 | |
| FTTGITCLGSVSALS | 801 | Q13423 | |
| DSSCNSSDGVLVTFS | 271 | Q8N2Y8 | |
| TSKDGEGSCYTSLIS | 96 | Q16799 | |
| ACGSSDGAISLLTYT | 121 | P55735 | |
| TSSINCITSFVSGFA | 346 | P23975 | |
| GEVFSNSSSCELTGS | 96 | Q9HC62 | |
| SCDSSFSSGISVFTA | 371 | Q08AM6 | |
| FDVAATGSLSTGTAT | 691 | Q9UGT4 | |
| SLAGAETSTCQADGT | 756 | Q9UGT4 | |
| SETASFAALSGGTLS | 511 | Q6ZMZ0 | |
| LLFLAVSSLGSCSTG | 41 | A6NIE9 | |
| SGLSEGSVTCSSAST | 381 | P02788 | |
| GCVSGTTTAEAENTS | 251 | Q9UMZ2 | |
| ETSTGSLCKESFSGQ | 666 | Q8N3X1 | |
| SGSCDISSNSDTFGS | 591 | Q6T4R5 | |
| DSSSSGSAAGKDCIT | 616 | O95255 | |
| IACLFSGSLSTISSA | 356 | Q9Y289 | |
| ASQSETSVCSGSLDG | 181 | Q53T94 | |
| CGTFSKTLSGSSSLE | 3036 | Q96Q15 | |
| GFLGETCLSESSDGS | 1086 | P28715 | |
| TSGGSCDASLAEEAS | 1111 | Q8TCU6 | |
| SLQGVHGSSSTFCSS | 486 | Q68DV7 | |
| LSKSNSGSFSGCESA | 431 | O43166 | |
| SGSFSGCESASFEST | 436 | O43166 | |
| LASSASGAESSFTLA | 156 | Q6ZUB0 | |
| SRSGTELSAVGSVCS | 4361 | O75592 | |
| CSSLRLFSSIDDGSG | 306 | Q9Y2I6 | |
| STLCSFISSSSGVSG | 351 | Q8IU85 | |
| SCNLGSSLSGFAVAT | 56 | P0CG40 | |
| GSGAANSAFCLASTS | 81 | P0CG40 | |
| SFFSTCGAGLQSLTG | 511 | Q9UP95 | |
| SSGTFLSGLSDCTNV | 91 | Q5JTH9 | |
| SASCNVVGSSLSSFG | 41 | Q8IXZ3 | |
| DSGVDSQGASCSLVS | 226 | Q7Z7C7 | |
| TDLLSSSLGTSGVDC | 21 | O00327 | |
| DSGFSDGSSECLSSA | 41 | Q9C0C6 | |
| VCFSRTSSGGSFVAS | 726 | A8K7I4 | |
| VSLSSDFIAGFCGET | 436 | Q96SZ6 | |
| LASSASGAESSFTLA | 156 | P0C874 | |
| SLCVSGETLAAGTSS | 156 | P82094 | |
| SASLIANGDSTSTCG | 256 | Q13107 | |
| DTNTRVLASCGFSSG | 381 | Q9C029 | |
| EGESSSLNCSYTVSG | 36 | A0A0B4J274 | |
| GSVSSAGSLDLSEAC | 936 | O14924 | |
| TECSNTFKSLGSTAG | 381 | Q2TAY7 | |
| SANFGGTLSTSICFD | 946 | Q12816 | |
| GTLSTSICFDGSPST | 951 | Q12816 | |
| SADFGGTLSTSVCFG | 996 | Q12816 | |
| GAVSTSACFSGAPIT | 1081 | Q12816 | |
| TSSGQVTLGDACSAS | 1426 | Q7Z4S6 | |
| SFDSGIAGLSSISQC | 256 | O95235 | |
| FTSEGSTLSGCDIEL | 791 | Q9BQI5 | |
| VFSTSSSIFQGSAVC | 326 | Q13214 | |
| TSCINLSVTDAGGSA | 386 | Q8WWL2 | |
| SGSSSSLLSAGCFFG | 386 | Q7Z6L1 | |
| ETSTGCLFAGSSLGK | 251 | O00442 | |
| SCSGVEFSTSGSSNT | 46 | P45880 | |
| VSSGSFCGLSRDSSS | 801 | C9JH25 | |
| GDATLCSGRFTISTL | 11 | P55017 | |
| EDCSSATSGSVGANS | 421 | O94876 | |
| FSGGCDLSGITDSSE | 311 | O75830 | |
| CFSFGIGEGTSTSLI | 416 | O00534 | |
| TACSASGVGLLSVSS | 1501 | Q70Z35 | |
| TSEAAISSDGLSCGS | 331 | Q86YV5 | |
| SGDSSEVGFCSNART | 436 | Q9NYK1 | |
| GVCGKTFSSGSSRTV | 406 | Q9BX82 | |
| EGSCGALDTLSSSST | 276 | Q9ULT6 | |
| VCTALISSASSVDFG | 991 | Q9Y2L5 | |
| GSFFVTGSSCGDLTV | 151 | Q8N9V3 | |
| FSGVSLFSLSTEGCD | 616 | O60602 | |
| SCTDSSGSFAKLNGL | 706 | Q8NFY4 | |
| GSFLLIIECGTESSS | 891 | O15016 | |
| TLCSSGTTAVIAGHS | 86 | Q14679 | |
| GSELSCTEGSLTSSL | 1671 | Q5T5U3 | |
| LASGEEFCSGSSSNL | 346 | Q6N021 | |
| GYCSLSVLASGSSAC | 411 | A8MYJ7 | |
| CLSLSLFVTGSADGS | 576 | Q6ZQQ6 | |
| VVGSDAVDSGTCSSA | 311 | Q8N5A5 | |
| STESLISSLGLGAFC | 16 | Q0VDI3 | |
| DTGFVCSRQSSLSSG | 341 | Q9H0E7 | |
| SQCTGLFSTTVLGGS | 1021 | Q6PFW1 | |
| LCASTLTVSSGSSRG | 356 | Q9ULE0 | |
| TASDVTSCVSGYALG | 16 | Q5TIE3 | |
| SDTSLTSLSDCFLGS | 361 | O60663 | |
| TSLSDCFLGSSDVGS | 366 | O60663 | |
| SVGSAAADSGTECLS | 446 | Q92539 |